Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Ciccopiedi

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Biomaterials|July 1, 1997
Cell growth on cordierite: an approach to the identification of reliable supports for continuous-flow solid-bed reactorsL Orlandi, R Solmi, A Krajewski, et al.
Transplantation Proceedings|April 1, 1996
Human MCP and DHF double transgenic mice are protected from human complement attack in an in vivo modelL C Mulder, M Mora, M Lazzeri, et al.
Transplantation Proceedings|February 1, 1995
Mice transgenic for human CD46 and CD55 are protected from human complement attackL C Mulder, M Mora, E Ciccopiedi, et al.
Transplantation Proceedings|February 1, 1996
Characterization of complement-mediated liver damage and protection in control and transgenic mice for human complement blockers MCP and DAFL C Mulder, M Mora, M Lazzeri, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Biomaterials|July 1, 1997
Cell growth on cordierite: an approach to the identification of reliable supports for continuous-flow solid-bed reactorsL Orlandi, R Solmi, A Krajewski, et al.
Transplantation Proceedings|April 1, 1996
Human MCP and DHF double transgenic mice are protected from human complement attack in an in vivo modelL C Mulder, M Mora, M Lazzeri, et al.
Transplantation Proceedings|February 1, 1995
Mice transgenic for human CD46 and CD55 are protected from human complement attackL C Mulder, M Mora, E Ciccopiedi, et al.
Transplantation Proceedings|February 1, 1996
Characterization of complement-mediated liver damage and protection in control and transgenic mice for human complement blockers MCP and DAFL C Mulder, M Mora, M Lazzeri, et al.
Pageof 1